Trial intelligence / Profile preview

SynePure and Catasyn for Superficial Partial-Thickness Burns

NCT05877638Terminated

Sponsor
Synedgen
Start
Mar 2023
Primary completion
Jun 2024
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Synedgen. Primary endpoint: Percentage of healing wound progress up to 21 days. Started Mar 2023; status: terminated.

Beyond the preview

Go deeper on NCT05877638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05877638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call